Exact Mass: 392.2562606
Exact Mass Matches: 392.2562606
Found 500 metabolites which its exact mass value is equals to given mass value 392.2562606,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ursodeoxycholate
Ursodeoxycholic acid is a bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones. It has a role as a human metabolite and a mouse metabolite. It is a bile acid, a dihydroxy-5beta-cholanic acid and a C24-steroid. It is a conjugate acid of an ursodeoxycholate. Ursodeoxycholic acid is an epimer of [chenodeoxycholic acid]. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. Ursodiol is a Bile Acid. Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones and to treat cholestatic forms of liver diseases including primary biliary cirrhosis. Ursodiol has been linked to rare instances of transient and mild serum aminotransferase elevations during therapy and to rare instances of jaundice and worsening of liver disease in patients with preexisting cirrhosis. Ursodeoxycholic acid is a natural product found in Myocastor coypus with data available. Ursodiol is a synthetically-derived form of ursodiol, a bile acid produced by the liver and secreted and stored in the gallbladder. Also produced by the Chinese black bear liver, ursodiol has been used in the treatment of liver disease for centuries. This agent dissolves or prevents cholesterol gallstones by blocking hepatic cholesterol production and decreasing bile cholesterol. Ursodiol also reduces the absorption of cholesterol from the intestinal tract. An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. See also: Dimethicone; pancrelipase; ursodiol (component of). Ursodeoxycholic acid, also known as ursodeoxycholate or acid deoxyursocholic, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Ursodeoxycholic acid is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. [HMDB] Ursodeoxycholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=128-13-2 (retrieved 2024-07-02) (CAS RN: 128-13-2). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Kalihinol A
C22H33ClN2O2 (392.22304280000003)
Trospium
C25H30NO3+ (392.22255700000005)
Trospium is only found in individuals that have used or taken this drug. It is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, and as Trosec in Canada. [Wikipedia]Trospium antagonizes the effect of acetylcholine on muscarinic receptors in cholinergically innervated organs. Its parasympatholytic action reduces the tonus of smooth muscle in the bladder.
3-Hydroxy-10'-apo-b,y-carotenal
3-Hydroxy-10-apo-b,y-carotenal is found in citrus. 3-Hydroxy-10-apo-b,y-carotenal isisolated from Sinton citrangequat. Prob. isolated from Sinton citrangequat. 3-Hydroxy-10-apo-b,y-carotenal is found in citrus.
Methyl (9Z)-6'-oxo-6,5'-diapo-6-carotenoate
Methyl (9Z)-6-oxo-6,5-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).
Hyodeoxycholic acid
Hyodeoxycholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 μM in CHO cells. Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 μM in CHO cells. Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 μM in CHO cells.
CPA(16:0/0:0)
cPA(16:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(16:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
20, 22-Dihydrodigoxigenin
20, 22-Dihydrodigoxigenin is a metabolite of digoxin. Digoxin is a purified cardiac glycoside and extracted from the foxglove plant, Digitalis lanata. Its corresponding aglycone is digoxigenin, and its acetyl derivative is acetyldigoxin. Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Digoxin preparations are commonly marketed under the trade names Lanoxin, Digitek, and Lanoxicaps. (Wikipedia)
(3a,5b,7a)-3,7-Dihydroxycholan-24-oic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Arterolane
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
Dextromoramide
C25H32N2O2 (392.24636519999996)
N,N'-Dibenzhydrylethane-1,2-diamine
AMN082 free base, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 free base potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 free base shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects[1][2].
N'-[(6-Oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide
VIPROSTOL
MG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/0:0)
MG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/0:0)
MG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/0:0)
MG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/0:0)
MG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/0:0)
MG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/0:0)
MG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
MG(0:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
MG(0:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
MG(0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
MG(0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
MG(0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
MG(0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
6alpha-Malonyloxymanoyl oxide
The malonate ester of a labdane diterpenoid. Isolated from the aerial parts of Stemodia foliosa, it exhibits antibacterial activity.
methyl 18-acetoxygrindelate|methyl-18-acetoxygrindeloate
3beta,11beta,15beta-trihydroxy-6alpha-acetoxy-ent-kaur-16-ene|melissoidesin
21-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one
21-Ac-(3alpha,5alpha,11beta)-3,11,21-Trihydroxypregnan-20-one
Di-Ac-5-[1-(2,2-Dimethylcyclopentylidene)ethyl]octahydro-4,4-dimethyl-1,3-isobenzofurandiol
3-Ac-(3beta,5beta,14beta)-3,14,21-Trihydroxypregnan-20-one
3-Ac-(3beta,5alpha,14beta,17alpha)-3,8,14-Trihydroxypregnan-20-one
2beta-methoxy-16-acetoxy-ent-labda-8(17),13Z-dien-15-oic acid
2-Acetoxy-5-methoxy-6-methyl-3-tridecyl-1,4-benzoquinone
10-Apo-Psi-carotin-10-saeure|apo-10-lycopenoic acid
3??-Hydroxy-7-acetoxy-4(18),13-clerodadien-15-oic acid methyl ester
(3S,5S,6R,9S)-megastigman-3,6,9-triol 3-O-beta-D-(-)-glucopyranoside|iso-dihydrodendranthemoside A|NSC# 742189
7alpha,12alpha,13alpha-trihydroxyabiet-8(14)-en-18-oic acid acetonide|aquilarabietic acid C
5alpha-pregna-3beta-acetoxy-12beta,16beta-diol-20-one
methyl (4S)-3,4-seco-4,21-dihydroxy-4-methyl-20-oxo-5alpha-pregna-8-en-3-oate|nodulisporisteriod B
(2R,3R,20R)-2,20-dihydroxy-3,21-dimethoxypregn-5-en-7-one|heligenin A
methyl 15,17-epoxy-17alpha-acetoxy-ent-isocopalan-16-oate
(17S)-16-oxo-2,3-secopregnan-2,3-dioic acid dimethyl ester
3-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one
21-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one
2-Methoxy-3-tridecyl-5-acetoxy-6-methyl-1,4-benzoquinone
8-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-indol-4-yl]-1-methyl-2,3,8,8a-tetrahydro-1h-pyrrolo[2,3-b]indol-3a-ol
3,16-Di-Ac-(3beta,5beta,16alpha,17beta)-Androstane-3,16,17-triol
6-alpha-malonyloxymanoyl oxide|6alpha-malonyloxymaloyl oxide
4alpha-angeloyloxy-5beta-hydroxy-13beta-methoxylupanine
2??-Hydroxy-7-acetoxy-3,13-clerodadien-15-oic acid methyl ester
7beta-acetoxy-15-hydroxylabda-8(17),13E-dien-19-oic acid methyl ester
3,17-Di-Ac-(3beta,5alpha,6alpha,17beta)-Androstane-3,6,17-triol
N-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide
Trospium
[C25H30NO3]+ (392.22255700000005)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3030
C19H36O8_[5-Hydroxy-2-(3-hydroxybutyl)-3,3-dimethylcyclohexyl]methyl beta-D-glucopyranoside
Dextromoramide
C25H32N2O2 (392.24636519999996)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
13,14-dihydro-16,16-difluoro Prostaglandin F2&alpha
C20H34F2O5 (392.23741780000006)
13,14-dihydro-16,16-difluoro Prostaglandin E1
C20H34F2O5 (392.23741780000006)
PAC-1
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent
Trospium
C25H30NO3+ (392.22255700000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Methyl (9Z)-6'-oxo-6,5'-diapo-6-carotenoate
apo-3-Zeaxanthinal
5-((3Z,6Z,9Z,12Z,15Z,18Z)-henicosa-3,6,9,12,15,18-hexaen-1-yl)resorcinol
(Z)-Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(9-octadecenyloxy)-, sodium salt,
C22H41NaO4 (392.29023860000007)
1,1-(9-(3-(DIMETHYLAMINO)PROPYL)-9H-CARBAZOLE-3,6-DIYL)BIS(2-METHYLPROPAN-1-ONE)
C25H32N2O2 (392.24636519999996)
Racemoramide
C25H32N2O2 (392.24636519999996)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
tert-butyl 1-benzylspiro[1,3-dihydroisoquinoline-4,4-piperidine ]-2-carboxylate
C25H32N2O2 (392.24636519999996)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(3-methoxyphenyl)- (9CI)
methyl (2s)-2-[[(2s)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]-3-phenylpropanoate
Toreforant
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78284 - Agent Affecting Integumentary System > C29708 - Anti-psoriatic Agent Toreforant is a potent and selective histamine H4 receptor (H4R) antagonist, with a Ki at the human receptor of 8.4 nM.
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate
C25H32N2O2 (392.24636519999996)
20,22-Dihydrodigoxigenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
(E)-N-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide
13,14-dihydro-16,16-difluoro Prostaglandin F2alpha
C20H34F2O5 (392.23741780000006)
1,1,2,2,5,5,6,6-Octaethyl-3,4,7,8-tetradehydro-1,2,5,6-tetrahydro-1,2,5,6-tetrasilocine
C20H40Si4 (392.22069600000003)
(E)-3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-4-hydroxybut-2-enoic acid
methyl (E)-7-[2-[(E)-4-ethenyl-4-hydroxyoct-1-enyl]-3-hydroxy-5-oxocyclopentyl]hept-5-enoate
N-[(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoyl]glycinate
C22H34NO5- (392.24368540000006)
A monocarboxylic acid anion that is the conjugate base of N-[(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoyl]glycine, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycinate
C22H34NO5- (392.24368540000006)
A monocarboxylic acid anion that is the conjugate base of N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine, obtained by deprotonation of the carboxy group; major species at pH 7.3.
2-oxo-3-[(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate
C25H30NO3- (392.22255700000005)
2-(4-Methylphenoxy)-1-[4-(4-phenylcyclohexyl)piperazin-1-yl]ethanone
C25H32N2O2 (392.24636519999996)
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
[3-carboxy-2-[(7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl]-trimethylazanium
C23H38NO4+ (392.28006880000004)
(1-acetyloxy-3-hydroxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
2-[Carboxy-(2-hydroxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium
Arterolane
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
AMN082 free base
AMN082 free base, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 free base potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 free base shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects[1][2].
1-Palmitylglycerone 3-phosphate(2-)
A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmitylglycerone 3-phosphate; major species at pH 7.3.
DG(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Gboxin
C22H33ClN2O2 (392.22304280000003)
Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F0F1 ATP synthase. Antitumour activity[1].
Isochenodeoxycholic Acid
-
(1s,2s,4ar,5r,8r,8ar)-8-[(2s,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,5-dimethyl-octahydronaphthalen-2-ol
C22H33ClN2O2 (392.22304280000003)
(4s,5s)-4-hydroxy-5-[(2r)-2-hydroxy-11-(4-hydroxyphenyl)-2-methylundecyl]-5-methyloxolan-2-one
(1s,2s,5r,10r,11r,14r,16r,17r)-17-hydroxy-17-(hydroxymethyl)-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-12-one
(1s,4ar,7s,8s,8as)-8-{2-[(2r,4r)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl (2s)-2-methylbutanoate
3a,9b-dihydroxy-5,8-dimethyl-1-methylidene-2h,4h,5h,5ah,6h,9h,9ah-naphtho[2,1-b]furan-9-yl octanoate
(2e,4e,6e,8e,10e,12e,14e)-15-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal
(2r,3r,4s,5s,6r)-2-{[(1r,2s,3s,4s)-3-[(3r)-3-hydroxybutyl]-4-(hydroxymethyl)-2,4-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (1r,2r,4ar,5s,8ar)-2-(acetyloxy)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
11-({6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl}methyl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one
(1r,3s,3ar,6r,7e,7ar)-3-(acetyloxy)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-hexahydro-1h-2-benzofuran-1-yl acetate
17-hydroxy-17-(hydroxymethyl)-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-12-one
methyl (1s,4ar,5r,7s,8ar)-7-(acetyloxy)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
8-(3,7-dimethylocta-2,6-dien-1-yl)-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol
(3r)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol
2β-hydroxy-7-acetoxy-3,13-clerodadien-15-oicacid methyl ester
{"Ingredient_id": "HBIN005393","Ingredient_name": "2\u03b2-hydroxy-7-acetoxy-3,13-clerodadien-15-oicacid methyl ester","Alias": "NA","Ingredient_formula": "C23H36O5","Ingredient_Smile": "CC1C(CC2(C(C1(C)CCC(=CC(=O)OC)C)CC(C=C2C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9750","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-methoxy-5-acetoxy-6-methyl-3-tridecyl-1,4-benzoquinone
{"Ingredient_id": "HBIN005896","Ingredient_name": "2-methoxy-5-acetoxy-6-methyl-3-tridecyl-1,4-benzoquinone","Alias": "NA","Ingredient_formula": "C23H36O5","Ingredient_Smile": "CCCCCCCCCCCCCC1=C(C(=O)C(=C(C1=O)OC(=O)C)C)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13823","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3α-hydroxy-7-acetoxy-4(18),13-clerodadien-15-oicacid methyl ester
{"Ingredient_id": "HBIN007950","Ingredient_name": "3\u03b1-hydroxy-7-acetoxy-4(18),13-clerodadien-15-oicacid methyl ester","Alias": "NA","Ingredient_formula": "C23H36O5","Ingredient_Smile": "CC1C(CC2(C(C1(C)CCC(=CC(=O)OC)C)CCC(C2=C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9751","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-hydroxy-7-acetoxy-4(18),13-clerodadien-15-oicacid methyl ester
{"Ingredient_id": "HBIN008235","Ingredient_name": "3\u03b2-hydroxy-7-acetoxy-4(18),13-clerodadien-15-oicacid methyl ester","Alias": "NA","Ingredient_formula": "C23H36O5","Ingredient_Smile": "CC1C(CC2(C(C1(C)CCC(=CC(=O)OC)C)CCC(C2=C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9752","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-[(acetyloxy)methyl]-5-(2-formyl-4-hydroxy-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)pent-2-enoic acid
methyl (4as,6ar,7as,8as,9r,9ar,9bs)-9-(acetyloxy)-4,4,6a,9b-tetramethyl-7-oxo-octahydro-1h-phenanthro[2,3-b]oxirene-7a-carboxylate
(4ar,5s,6as,7r,10ar,11ar,11bs)-7,10a-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
(2e,6e,10e)-12-[(3s,5r)-2,3-dihydroxy-5-methoxy-6-oxocyclohex-1-en-1-yl]-2,6,10-trimethyldodeca-2,6,10-trienoic acid
(3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
[(3r,6r)-6-[(1s,4s,6s,10r,12s)-4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl]-6-hydroxy-3-methyl-1,2-dioxin-3-yl]methyl acetate
methyl 3-[(3s,3as,6s,7r,9br)-3-acetyl-7-[(1r)-1,2-dihydroxyethyl]-3a,6-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,9bh-cyclopenta[a]naphthalen-6-yl]propanoate
3-{[(1s,2s,7s,9s,10s,12r,13s)-9-hydroxy-2,6,6,13-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0²,⁷]hexadecan-12-yl]oxy}-3-oxopropanoic acid
(4s,6s,7r,8r,13r,17r)-8-hydroxy-4,6,10-trimethyl-17-propyl-14,18-dioxatricyclo[11.2.2.1⁴,⁷]octadec-9-ene-11,15,16-trione
(2r,3r,4s,5r,6r)-2-{[(2r)-1-hydroxy-4-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,2s,5r,10r,11r,15r,16s,17r)-17-(hydroxymethyl)-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icos-13-ene-15,17-diol
2-{[(1r,2s,4ar,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-5,11-dimethyl-4,12-dioxa-6,10-diazatricyclo[7.3.0.0³,⁷]dodeca-1,3(7),5,8,10-pentaene
C25H32N2O2 (392.24636519999996)
(1s,2s,4ar,8ar)-1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(1s,2s,3r,4r,7r,8r,11s,14r,17s)-14-hydroxy-4,8,11-trimethyl-15-methylidene-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate
(2r,3r,4s,5s,6r)-6-({[(1s,4r,5s)-4-[(3r)-3-hydroxybutyl]-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}methyl)oxane-2,3,4,5-tetrol
[(1r,2r,4r,9s,10s,11s,13s,16r)-2,11,16-trihydroxy-5,5-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-9-yl]methyl acetate
(1r,4s,6s,7r,8r,9e,13r,17r)-8-hydroxy-4,6,10-trimethyl-17-propyl-14,18-dioxatricyclo[11.2.2.1⁴,⁷]octadec-9-ene-11,15,16-trione
2,6,11-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
2-{[4-(3-hydroxybutyl)-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,6e)-8-{[(2e,6e)-8-(acetyloxy)-2,6-dimethylocta-2,6-dienoyl]oxy}-2,6-dimethylocta-2,6-dienoic acid
1-(acetyloxy)-7-hydroxy-1,4a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-hexahydronaphthalen-2-yl 2-methylbut-2-enoate
7-[2-(acetyloxy)propan-2-yl]-3a-hydroxy-1,4-dimethyl-2-oxo-3,4,5,6,7,8-hexahydroazulen-6-yl 2-methylbut-2-enoate
3-(acetyloxy)-7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-hexahydro-1h-2-benzofuran-1-yl acetate
(7r,8r,8ar)-3-[(1e)-2-{5-[(2s)-butan-2-yl]-2,2,4-trimethyl-1,3-dioxolan-4-yl}ethenyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1h-isochromen-6-one
methyl (2e)-5-[(1r,2s,3r,4ar,6s,8ar)-3-(acetyloxy)-6-hydroxy-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate
(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8,10,11-trihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate
4-hydroxy-3,5-dimethyl-6-(2,8,13-trihydroxy-5,11-dimethyltrideca-3,5,9,11-tetraen-1-yl)-5,6-dihydropyran-2-one
3,9-dihydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13-oxabicyclo[10.3.2]heptadeca-4,7-dien-11-yl acetate
(1s,3s,5s,8r,11r,12s)-3-hydroxy-8,12-dimethyl-4,15-dimethylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁵,⁸]octadecan-11-yl acetate
3-{[(2s,4as,5r,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid
5'-hydroxy-2',5,5,6'-tetramethylspiro[1,4-dioxolane-2,13'-tetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecane]-6'-carboxylic acid
[2,16-dihydroxy-5-(hydroxymethyl)-5-methyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-9-yl]methyl acetate
10-hydroxy-17-methoxy-7,15,19,20-tetramethyl-3,5,11-trioxapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icos-16-en-18-one
(2e,6e)-6-[(4z)-6-(acetyloxy)-4-methylhex-4-en-1-ylidene]-2-(4-methylpent-3-en-1-yl)hept-2-enedioic acid
12-(2,3-dihydroxy-5-methoxy-6-oxocyclohex-1-en-1-yl)-2,6,10-trimethyldodeca-2,6,10-trienoic acid
(1s,3s,5s,8e,10r,12r,13s)-10-hydroxy-5,9,13-trimethyl-16-methylidene-15-oxo-4,14-dioxatricyclo[11.3.2.0³,⁵]octadec-8-en-12-yl acetate
(2r,3r,3ar,4s,7s,7ar)-4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate
3-{[5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid
(2r,3r,3ar,4s,7s,7ar)-4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2s)-2-methylbutanoate
ethyl 3-hydroxy-3,7,10-trimethyl-5-(2-methylprop-1-en-1-yl)-2,4-dioxo-hexahydro-5h-indeno[4,3a-b]pyran-10a-carboxylate
[9,13-dihydroxy-6-(hydroxymethyl)-2,6-dimethyl-5-oxotetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadec-10-en-13-yl]methyl acetate
(16r)-2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-12-yl acetate
(2s,9r,13s,14r,15s,17s)-16-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,11-dione
3-[(acetyloxy)methyl]-5-[2-(formyloxy)-5,5,8a-trimethyl-1,2,4a,6,7,8-hexahydronaphthalen-1-yl]pent-2-enoic acid
(2s,3r,4r,4ar,8ar)-4-[2-(furan-3-yl)ethyl]-3,4-dihydroxy-3,4a,8,8-tetramethyl-1-oxo-tetrahydro-2h-naphthalen-2-yl acetate
7,8-dihydroxy-7-methyl-3-{2-[2,2,4-trimethyl-5-(sec-butyl)-1,3-dioxolan-4-yl]ethenyl}-8,8a-dihydro-1h-isochromen-6-one
{2,11,16-trihydroxy-5,5-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-9-yl}methyl acetate
(3as,4s,6r,7s)-7-[2-(acetyloxy)propan-2-yl]-3a-hydroxy-1,4-dimethyl-2-oxo-3,4,5,6,7,8-hexahydroazulen-6-yl (2z)-2-methylbut-2-enoate
(1r,2r,4r,9r,10s,11r,12r,13s,16r)-2,11,12-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl acetate
2-({4-[4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,2r,5s,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol
C22H33ClN2O2 (392.22304280000003)
(1s,2r,4s,8r,9r,10s,15r)-2-hydroxy-1,10-dimethyl-5,14-dimethylidene-6-oxo-7,18-dioxatricyclo[13.2.1.0⁴,⁸]octadecan-9-yl acetate
(2s,4ar,7s,8r,8ar)-8-(acetyloxy)-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl (2z)-2-methylbut-2-enoate
(1r,4r,9r,10s,11r,12r,13s,15r,16r)-11,12,16-trihydroxy-5,5,9-trimethyl-14-methylidene-2-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
9-ethoxy-6-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl 2-methylbut-2-enoate
methyl (2e)-5-[(1r,2s,3r,4ar,6r,8ar)-3-(acetyloxy)-6-hydroxy-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate
(6-{4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl}-6-hydroxy-3-methyl-1,2-dioxin-3-yl)methyl acetate
{2,8,16-trihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methyl acetate
(1r,4as,5r,5's,8as)-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate
1-{3-[(acetyloxy)methyl]-4-carboxybut-3-en-1-yl}-5,5,8a-trimethyl-1,2,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid
(1s,2r,4ar,8ar)-1-(acetyloxy)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
(5s)-1-(4-hydroxy-3-methoxyphenyl)-3-oxotetradecan-5-yl acetate
(1s,2r,4s,8r,9s,10r,15r)-9-hydroxy-1,10-dimethyl-5,14-dimethylidene-6-oxo-7,18-dioxatricyclo[13.2.1.0⁴,⁸]octadecan-2-yl acetate
(1r,4ar,5'r,8ar)-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate
4,12-dihydroxy-5-isopropyl-6,9-dimethyl-14-oxo-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-13(16)-en-3-yl acetate
(1s,3s,4s,6r,7s,9s,10s,11s,13s)-6,7,11-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,2s,3as,3br,5as,7s,9as,9bs,11r,11as)-1-acetyl-2,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
10-ethoxy-3,9-dihydroxy-2-(1-hydroxypropan-2-yl)-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-1,4-dione
4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 2-methylbutanoate
1-methyl 4-[1,2,5-trimethyl-1-(3-oxobutyl)-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl butanedioate
methyl (3r)-5-[(4s,4ar,8as)-4-(acetyloxy)-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl]-3-methylpentanoate
(1s,4as,5'r,8as)-2-[(acetyloxy)methyl]-5,5,5',8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydrospiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid
[(1s,7r,10r,11r)-4-[(acetyloxy)methyl]-10,11-dimethyl-3-oxotricyclo[5.3.1.0¹,⁵]undec-4-en-11-yl]methyl 3-hydroxy-3-methylbutanoate
(1r,3s,5s,7e,9s,12s,13r)-9-hydroxy-5,9,13-trimethyl-16-methylidene-15-oxo-4,14-dioxatricyclo[11.3.2.0³,⁵]octadec-7-en-12-yl acetate
(1r,4s,6s,10r,13s,14r)-13-hydroxy-4,13-dimethyl-9,17-dimethylidene-16-oxo-5,15-dioxatricyclo[12.3.1.0⁴,⁶]octadecan-10-yl acetate
(2s,3s,3ar,5r,6s,7as)-2-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3-methyl-3a-(prop-2-en-1-yl)-hexahydro-1-benzofuran-6,7a-diol
(3s,4r,5r,6s)-5-methoxy-4-[(2r,3s)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (2e)-3-[(2r,3r)-3-methyloxiran-2-yl]prop-2-enoate
(1s,4r,5s,8r,9r,10s,12s,13s,15s)-8-(acetyloxy)-12,15-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(1s,2s,5r,6s,7r,12s,13r)-13-[(acetyloxy)methyl]-5,13-dihydroxy-2,6-dimethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadec-10-ene-6-carboxylic acid
5-methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl 3-(3-methyloxiran-2-yl)prop-2-enoate
(1r,2r,4s,6r,9r,10s,12s,13s,16r)-2,6,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-12-yl acetate
(1r,2s,5r,6s)-1-[(1s,4e)-1-hydroxy-5-[(1s,3r)-3-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpenta-2,4-dien-1-yl]-4-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol
[(3r,6s)-6-[(1s,4s,6s,10r,12s)-4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl]-6-hydroxy-3-methyl-1,2-dioxin-3-yl]methyl acetate
(2r,3r,4s,5s,6r)-6-({[(2r)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol
6-[6-(acetyloxy)-4-methylhex-4-en-1-ylidene]-2-(4-methylpent-3-en-1-yl)hept-2-enedioic acid
(4r,5r,6r)-5-[(9s)-9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-hydroxy-2-methoxy-6-methylcyclohex-2-en-1-one
(2s,4s,4as,5s,7s,10ar)-4,5-dihydroxy-7-(3-hydroxyprop-1-en-2-yl)-1,1,4a-trimethyl-10-oxo-3,4,4b,5,6,7,8,10a-octahydro-2h-phenanthren-2-yl acetate
4-methoxy-5-methyl-3,6-dioxo-2-tridecylcyclohexa-1,4-dien-1-yl acetate
6-(acetyloxy)-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-4-yl 2-methylbutanoate
[7-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-[2-(5-oxo-2h-furan-3-yl)ethyl]-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl acetate
3,12-dihydroxy-5-isopropyl-6,9-dimethyl-14-oxo-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-13(16)-en-4-yl acetate
(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2,10-dimethylundeca-2,4-dienimidic acid
(1s,3r,4s,5s,6s)-4-[(1s,3ar,7ar)-1-hydroxy-7,7-dimethyl-hexahydro-2-benzofuran-3a-yl]-5-formyl-3-hydroxy-7-methylidenebicyclo[3.2.1]octan-6-yl acetate
(4s,4as,5r,6s,8as)-6-(acetyloxy)-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-4-yl (2r)-2-methylbutanoate
1-[2-(furan-3-yl)ethyl]-1-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3-oxo-tetrahydro-4h-naphthalen-2-yl acetate
8-[2-(4-hydroxy-6-oxooxan-2-yl)ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl 2-methylbutanoate
5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate
(1r,2s,5s,7r,8r,9s,10s,11r,18r)-7,9,18-trihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-10-yl acetate
9-hydroxy-5,9,13-trimethyl-18-methylidene-17-oxo-4,16-dioxatricyclo[13.3.0.0³,⁵]octadec-7-en-14-yl acetate
5-(acetyloxy)-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 3-methylbutanoate
(1s,4ar,5s,5'r,8ar)-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate
11-methyl-10-{[(5s,9s)-7-methyl-13-azatricyclo[7.3.1.0⁵,¹³]tridecan-1-yl]methyl}-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one
3-hydroxy-8,12-dimethyl-4,15-dimethylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁵,⁸]octadecan-11-yl acetate
(1s,3r,3as,6s,7e,7as)-3-(acetyloxy)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-hexahydro-1h-2-benzofuran-1-yl acetate
(5s,7e,9s,11s,12r,13r)-9-hydroxy-12-isopropyl-5,9-dimethyl-3,15-dioxo-14-oxabicyclo[11.2.1]hexadeca-1(16),7-dien-11-yl acetate
3-hydroxy-1-methoxy-7-methyl-4-(6-methylhept-5-en-2-yl)-1h,3h,3ah,4h,5h,6h,9h-cyclonona[c]furan-5-yl acetate
3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(1s,3s,4s,7r,8z,11r,12s)-3-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadec-8-en-11-yl acetate
9-hydroxy-12-isopropyl-5,9-dimethyl-3,15-dioxo-14-oxabicyclo[11.2.1]hexadeca-1(16),7-dien-11-yl acetate
(4z,18z)-29-oxa-10,24-diazahexacyclo[22.3.1.1¹²,¹⁵.0¹,¹¹.0³,¹⁰.0¹³,²⁷]nonacosa-4,12,14,18-tetraene
methyl 5-[4-(acetyloxy)-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl]-3-methylpentanoate
(1s,4r,9r,10s,11r,12r,13r,15r,16s)-11,12,16-trihydroxy-5,5,9-trimethyl-14-methylidene-2-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
[(2s,3ar,5as,9as,9br)-2-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-6,6,9a-trimethyl-octahydro-1h-naphtho[2,1-b]furan-3a-yl]methyl acetate
4-[2-(furan-3-yl)ethyl]-3,4-dihydroxy-3,4a,8,8-tetramethyl-1-oxo-tetrahydro-2h-naphthalen-2-yl acetate
(3ar,5s,5ar,9s,9ar,9bs)-3a,9b-dihydroxy-5,8-dimethyl-1-methylidene-2h,4h,5h,5ah,6h,9h,9ah-naphtho[2,1-b]furan-9-yl octanoate
(1r,2s,5r,6s,9r,11s,13r)-1,5,9-trimethyl-14-methylidene-15-oxo-10,16,19-trioxatetracyclo[11.3.2.1²,⁵.0⁹,¹¹]nonadecan-6-yl acetate
(1r,3ar,5r,6s,8s,8as)-1,6,8-trihydroxy-1-isopropyl-3a,6-dimethyl-hexahydro-2h-azulen-5-yl 4-hydroxybenzoate
methyl 5-[3-(acetyloxy)-6-hydroxy-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate
(1r,2r,4r,6s,9r,10r,13s,16r)-2,10,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
2,12,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(2r,3s,3ar,5r,6r,7as)-2-(3,4-dimethoxyphenyl)-5,7a-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-hexahydro-1-benzofuran-6-ol
5-formyl-2,12,16-trihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
5,6-dihydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate
(1s,2r,4ar,8ar)-1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate
(1s,3r,6s,7s,10r,15r,16r,20r)-7,16-bis(hydroxymethyl)-16,20-dimethyl-4,8-dioxahexacyclo[10.8.0.0³,⁵.0³,¹⁰.0⁷,⁹.0¹⁵,²⁰]icos-12-ene-6,10-diol
[(3as,4as,8r,8as,10r)-4a,8,10-trihydroxy-1-isopropyl-3a-methyl-5-methylidene-2-oxo-3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-8a-yl]methyl acetate
2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-12-yl acetate
(3r,3as,4s,6s,7s,8ar)-3,6,7-trihydroxy-3-isopropyl-6,8a-dimethyl-hexahydro-1h-azulen-4-yl 4-hydroxybenzoate
(1r,4s,4ar,5s,6r,8r,8ar)-5-[2-(furan-3-yl)ethyl]-4,8-dihydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1s,3s,4s,6s,9r,10s,11r,12r,13r)-3,6,12-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,4s,9s,10r,11r,12r,13s,15r,16r)-11,12,16-trihydroxy-5,5,9-trimethyl-14-methylidene-2-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl 2,3-dimethyloxirane-2-carboxylate
4-hydroxy-3-[(2e)-6-hydroxy-6-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methylhex-2-en-1-yl]benzoic acid
(1r,3r,4ar,5s,6r,8s,8as)-3-hydroxy-5,6,8a-trimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8-yl acetate
5-[3-(acetyloxy)-7-hydroxy-1,2,4a-trimethyl-5-methylidene-6-oxo-2,3,4,8a-tetrahydronaphthalen-1-yl]-3-methylpentanoic acid
(2r,3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(3ar,5r,6s,15s,15ar)-5,6-dihydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate
(1r,3s,5s,7z,9r,13s,14r,15s)-9-hydroxy-5,9,13-trimethyl-18-methylidene-17-oxo-4,16-dioxatricyclo[13.3.0.0³,⁵]octadec-7-en-14-yl acetate
4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate
(1s,2r,4r,5s,9s,10s,12r)-5-hydroxy-12-methoxy-6-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate
1-[1-hydroxy-5-(5-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl)-3-methylpenta-2,4-dien-1-yl]-4-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol
(1r,9s)-11-{[(1r,9s)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]methyl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one
2-{[4-(3-hydroxybutyl)-3-(hydroxymethyl)-3,5-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
ethyl (3s,4as,5s,7s,7ar,10s,10as)-3-hydroxy-3,7,10-trimethyl-5-(2-methylprop-1-en-1-yl)-2,4-dioxo-hexahydro-5h-indeno[4,3a-b]pyran-10a-carboxylate
[(1r,4r,10s,11s,13s,16r)-2,11,16-trihydroxy-5,5-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-9-yl]methyl acetate
8-[5-(2-chloropropan-2-yl)-2-methyloxolan-2-yl]-2,5-diisocyano-2,5-dimethyl-octahydronaphthalen-1-ol
C22H33ClN2O2 (392.22304280000003)
(2''s,3s,3''r,4''as,5's,8''as)-2''-hydroxy-2'',5'',5'',8''a-tetramethyl-4''-oxo-4''a,6'',7'',8''-tetrahydro-2h,3''h-dispiro[furan-3,2'-oxolane-5',1''-naphthalen]-3''-yl acetate
2,3,7-trihydroxy-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-10-yl acetate
6,9,12-trimethyl-12-(3-oxoprop-1-en-1-yl)-3-(2-oxopropyl)-2,11-dioxatricyclo[6.4.1.0⁴,¹³]tridecan-5-yl acetate
(4bs,8as,9s,10s)-10-ethoxy-3,9-dihydroxy-2-[(2s)-1-hydroxypropan-2-yl]-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-1,4-dione
8-{[8-(acetyloxy)-2,6-dimethylocta-2,6-dienoyl]oxy}-2,6-dimethylocta-2,6-dienoic acid
(1r,3s,3ar,6r,7e,7ar)-3-(acetyloxy)-7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-hexahydro-1h-2-benzofuran-1-yl acetate
(1r,3s,5s,7e,9r,12s,13r)-9-hydroxy-5,9,13-trimethyl-16-methylidene-15-oxo-4,14-dioxatricyclo[11.3.2.0³,⁵]octadec-7-en-12-yl acetate
methyl 7-(acetyloxy)-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(4ar,5s,6as,7r,10as,11ar,11bs)-7,10a-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
3,12-dimethyl (1r,2e,6r,8r,11z,15s)-15-isopropyl-8-methyl-7,16-dioxatricyclo[13.1.0.0⁶,⁸]hexadeca-2,11-diene-3,12-dicarboxylate
2-{[4-(3,4-dihydroxybutyl)-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2r)-2-methylbutanoate
(1s,4r,7r,8s,12r)-7-[(2z)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-12-hydroxy-4-methyl-3,14-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
4-methoxy-2-methyl-3,6-dioxo-5-tridecylcyclohexa-1,4-dien-1-yl acetate
(1r,3s,4r,6s,9r,10r,11s,13r,15r)-6,11,15-trihydroxy-5,5,9,15-tetramethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,2r,3r,5s,8r,9r,10r)-2,5,9-trihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-10-yl acetate
(1r,2r,3r,4r,7s,9r,10r,11r,14r)-2,3,7-trihydroxy-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-10-yl acetate
(1s,3s,4r,6s,8s,9r,10s,11s,13s)-3,6,8-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,2s,3s,4r,5r,6r,9r,12s)-4,12-dihydroxy-5-isopropyl-6,9-dimethyl-14-oxo-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-13(16)-en-3-yl acetate
(1r,4ar,5s,6r,8s,8ar)-8-hydroxy-5,6-dimethyl-5-[2-(3-oxocyclopent-1-en-1-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl hydrogen carbonate
(1s,2s,6s,7r,8s,12r,14s,15s,19s,20s)-10-hydroxy-17-methoxy-7,15,19,20-tetramethyl-3,5,11-trioxapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icos-16-en-18-one
[(1r,2r,4s,5s,9r,10s,13r)-2-hydroxy-14-(methoxymethyl)-5,9-dimethyl-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(1r,2r,3r,4s,6s,9s,10s,11s,13s)-2,6,11-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,3s,4r,7r,11r,12r)-3-hydroxy-4,12-dimethyl-8,15-dimethylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-11-yl acetate
(4ar,5s,7r,8s,8ar,9ar)-8-hydroxy-9a-methoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-7-yl (2e)-3-methylpent-2-enoate
11-methyl-10-({7-methyl-13-azatricyclo[7.3.1.0⁵,¹³]tridecan-1-yl}methyl)-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one
[(1r,2r,4r,5s,9s,10s,13s,16r)-2,16-dihydroxy-5-(hydroxymethyl)-5-methyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-9-yl]methyl acetate
8-(acetyloxy)-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl 2-methylbut-2-enoate
(2r,3r,4s,5s,6r)-2-{[(2r)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,2s,4ar,8ar)-1-(acetyloxy)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
methyl (1r,2r,4ar,4bs,8as,10r,10ar)-10-(acetyloxy)-1-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthrene-2-carboxylate
5-(9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-4-hydroxy-2-methoxy-6-methylcyclohex-2-en-1-one
(1r,2s,5s,6s,7s,12r)-5-(acetyloxy)-12-isopropyl-2,6-dimethyl-13,14-dioxatetracyclo[10.2.2.0¹,¹⁰.0²,⁷]hexadec-10-ene-6-carboxylic acid
(1s,2r,4as,5s,8as)-1-[2-(furan-3-yl)ethyl]-1-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3-oxo-tetrahydro-4h-naphthalen-2-yl acetate
(1r,2r,3r,5s,8r,9r,10r)-2,5,10-trihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-9-yl acetate
(1r,2r,3r,4r,7s,9r,10r,11r,14s)-3,7,10-trihydroxy-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-2-yl acetate
4-{2-[(1s,2r,4s,5r,7s,10s,11r,12s)-4-ethoxy-2-hydroxy-11,12-dimethyl-3,6-dioxatetracyclo[8.4.0.0¹,⁵.0⁵,⁷]tetradecan-11-yl]ethyl}-5h-furan-2-one
methyl (2e)-5-[(1s,4r,4ar,8as)-2-formyl-4-hydroxy-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-[(formyloxy)methyl]pent-2-enoate
(6e,8e,10e,12e,14e)-15-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal
(2e)-5-[(1s,2s,4ar,8ar)-2-(formyloxy)-5,5,8a-trimethyl-1,2,4a,6,7,8-hexahydronaphthalen-1-yl]-3-[(acetyloxy)methyl]pent-2-enoic acid
(2r,3r,4s,5s,6r)-2-{[(2s)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4r,8s,9r,10s,12s,13r,16s)-2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-12-yl acetate
4-[2-(furan-3-yl)-2-hydroxyethyl]-4-(hydroxymethyl)-5,7a,7b-trimethyl-hexahydro-1ah-naphtho[1,2-b]oxiren-6-yl acetate
1-chloro-5-isocyano-8-[5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-2,5-dimethyl-octahydronaphthalen-2-ol
C22H33ClN2O2 (392.22304280000003)
(1s,3s,4r,6s,8s,9r,10s,11r,13s)-3,6,8-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(2r,3r,4s,5s,6r)-2-{[(2s)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3ar,4r,5ar,6r,9r,9as,9bs)-9-ethoxy-6-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl (2e)-2-methylbut-2-enoate
3-[3-(2-hydroxyacetyl)-7-(1-hydroxyethyl)-3a,6-dimethyl-8-oxo-1h,2h,3h,4h,5h,7h,9h,9bh-cyclopenta[a]naphthalen-6-yl]propanoic acid
3-({9-hydroxy-2,6,6,13-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0²,⁷]hexadecan-12-yl}oxy)-3-oxopropanoic acid
4-[(3as,8as)-3a-hydroxy-1-methyl-2h,3h,8ah-pyrrolo[2,3-b]indol-8-yl]-3-[2-(dimethylamino)ethyl]-1h-indol-5-ol
(1s,2s,6s,7r,8s,10r,12r,14s,15s,19s,20s)-10-hydroxy-17-methoxy-7,15,19,20-tetramethyl-3,5,11-trioxapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icos-16-en-18-one
1-[(1s,2r,4as,8ar)-1,2,5-trimethyl-1-(3-oxobutyl)-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate
(1r,2s,5r,6s,9s,11r,13r)-1,5,9-trimethyl-14-methylidene-15-oxo-10,16,19-trioxatetracyclo[11.3.2.1²,⁵.0⁹,¹¹]nonadecan-6-yl acetate
1,4a,6-trimethyl-5-({2,3,5-trihydroxy-4-methylidene-7-oxabicyclo[4.1.0]heptan-1-yl}methyl)-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid
methyl 5-[3-(acetyloxy)-7-hydroxy-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate
(2s,3s,3ar,5r,6r,7as)-2-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3-methyl-3a-(prop-2-en-1-yl)-hexahydro-1-benzofuran-6,7a-diol
(7r,8r,8ar)-3-[(1e)-2-[(4r,5s)-5-[(2s)-butan-2-yl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]ethenyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1h-isochromen-6-one
(2r,4ar,7r,8s,8ar)-8-(acetyloxy)-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl (2z)-2-methylbut-2-enoate
15-(2-hydroxy-5-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)pentadec-2-enoic acid
[(3ar,5s,6s,15as)-5,6-dihydroxy-10,14-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-6-yl]methyl acetate
(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2-methyldodeca-2,4-dienimidic acid
{4-[(acetyloxy)methyl]-10,11-dimethyl-3-oxotricyclo[5.3.1.0¹,⁵]undec-4-en-11-yl}methyl 3-hydroxy-3-methylbutanoate
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2s)-2-methylbutanoate
6,11,15-trihydroxy-5,5,9,15-tetramethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1s,2s,4ar,8ar)-1-(acetyloxy)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
(2r,3s,4s,4as,8ar)-4-[2-(furan-3-yl)ethyl]-3,4-dihydroxy-3,4a,8,8-tetramethyl-1-oxo-tetrahydro-2h-naphthalen-2-yl acetate
(3ar,4as,5r,7s,7as,8r,9as)-5-(acetyloxy)-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 3-methylbutanoate
(1r,2r,4s,5s,9s,10s,12s,13r,15r,16r)-5-formyl-2,12,16-trihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(1r,2s,4r,9r,10s,13s,16s,18s,19s)-18-hydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl acetate
5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate
(2z)-5-[(1r,4ar,7r,8ar)-7-methoxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-[(acetyloxy)methyl]pent-2-enoic acid
methyl 2-[(2r,3r,4ar,7s)-3-(acetyloxy)-4a,8-dimethyl-7-[(2-methylpropanoyl)oxy]-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
(2r,3r,5s,8r,9r,10r)-2,5,10-trihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-9-yl acetate
(3ar,5s,6r,15s,15ar)-5,6-dihydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate
(1r,2s,5r,6s,9s,11s,13r)-1,5,9-trimethyl-14-methylidene-15-oxo-10,16,19-trioxatetracyclo[11.3.2.1²,⁵.0⁹,¹¹]nonadecan-6-yl acetate
2-{[1-hydroxy-4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
7,10a-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
(6s,10r,16s)-2,10,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(6s,10r)-2,10,16-trihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(1s,2r,4s,9s,10r,13r,16r,18r,19r)-18-hydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl acetate
13-[(acetyloxy)methyl]-5,13-dihydroxy-2,6-dimethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadec-10-ene-6-carboxylic acid
(2r,3r,4s,5s,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4s,5s,9s,10s,12s,13r,15r,16r)-5-formyl-2,12,16-trihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
3-[(3s,3as,6s,7r,9br)-3-(2-hydroxyacetyl)-7-[(1s)-1-hydroxyethyl]-3a,6-dimethyl-8-oxo-1h,2h,3h,4h,5h,7h,9h,9bh-cyclopenta[a]naphthalen-6-yl]propanoic acid
(1ar,3ar,4s,5s,6r,7ar,7bs)-4-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-4-(hydroxymethyl)-5,7a,7b-trimethyl-hexahydro-1ah-naphtho[1,2-b]oxiren-6-yl acetate
7,9,18-trihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-10-yl acetate
(1r,2r,5r,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol
C22H33ClN2O2 (392.22304280000003)